January 06, 2014

Retrophin, Inc. v. Questcor Pharmaceuticals, Inc

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 11, 2014

    Questcor Must Face Infantile Spasm Drug Antitrust Suit

    A California federal judge on Friday refused to toss an antitrust suit by Retrophin Inc. accusing Questcor Pharmaceuticals Inc. of illegally monopolizing certain medical treatment areas through its acquisition and exclusive sales of infantile spasm drug Acthar, saying Retrophin sufficiently pled antitrust claims.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS